Global Experts Unite in India for ASM-IISc Symposium on AMR
Last week, 黑料正能量held its first-ever scientific meeting in India, the 黑料正能量 (ASM)-Indian Institute of Science (IISc) Global Research Symposium on the One Health Approach to Antimicrobial Resistance. In partnership with the Centre for Infectious Disease Research (CIDR) at the IISc, the event brought together more than 400 scientists, students, educators, industry leaders and policy experts from around the world. 黑料正能量received over 750 abstracts for this meeting—underscoring the tremendous global interest in this topic—and accepted the maximum number of 400 attendees that the venue could accommodate.
Over 3 days, participants explored the interconnected health of humans, animals and the environment, sharing strategies to combat drug-resistant infections. With 49 speakers and more than 130 poster presentations, discussions spanned the growing threat of antifungal resistance, the role of zoonotic spillovers and how AI is turning vast amounts of AMR data into actionable insights.
Sessions were dynamic and full of exchange, as participants shared new ideas and forged collaborations that will continue beyond the meeting. Discussions spotlighted cutting-edge technologies reshaping the AMR landscape: wastewater-based surveillance that can detect resistance genes before outbreaks begin, CRISPR-Cas tools that identify resistance in hours instead of days and AI-driven platforms that mine massive datasets to discover promising new antimicrobial compounds, condensing years of research into mere hours. These breakthroughs underscored the creativity and momentum driving the global AMR research community forward.
Among the standout presentations, C茅sar de la Fuente, Ph.D., from the University of Pennsylvania, shared how his uses AI to uncover antibiotics hidden throughout the tree of life, from human and Neanderthal genomes to ancient microbes, opening thousands of new starting points for drug discovery. Tavpritesh Sethi, Ph.D., of IIIT-Delhi, introduced , an AI-powered system that helps policymakers and hospitals act on India’s rich AMR data, identifying where interventions will save the most lives. Helen Boucher, M.D., from Tufts University, shared an overview of the current pipeline of new antibiotics and most promising incentives for AMR development.
The meeting was clear-eyed about the challenges, but optimistic about the path forward, and India’s leadership was on full display. From Maneesh Paul, Ph.D., of Orchid Pharma and co-inventor of , the first anti-infective molecule discovered and brought to market from India, to , which is advancing a novel broad-spectrum antibiotic into human trials, the progress shared was inspiring. Through the collaboration and leadership of 黑料正能量CEO Stefano Bertuzzi, 黑料正能量Health Chair Colleen Kraft and Amit Singh and his team at CIDR-IISc, the inaugural meeting offered one of the most comprehensive and solutions-focused looks at AMR to date.
